首页|期刊导航|兰州大学学报(医学版)|妊娠期高血压孕妇血清CTRP6、IP-16与妊娠结局的相关性

妊娠期高血压孕妇血清CTRP6、IP-16与妊娠结局的相关性OA

Correlation between serum levels of CTRP6,IP-16 and pregnan-cy outcomes in pregnant women with hypertensive diseases

中文摘要英文摘要

目的 探讨妊娠期高血压(HDP)孕妇血清C1q/肿瘤坏死因子相关蛋白6(CTRP6)、γ干扰素诱导蛋白-16(IP-16)质量浓度与妊娠结局的相关性.方法 选取扬州大学附属淮安市妇幼保健院2022年1月—2023年6月收治的153例HDP孕妇为HDP组,另选取同期167例健康孕妇为健康组.HDP孕妇分为妊娠高血压组(n=84)、轻度子痫前期组(n=43)和重度子痫前期组(n=26),另根据妊娠结局分为结局不良组(n=59)和结局良好组(n=94).HDP孕妇不良妊娠结局的影响因素采用多因素Logistic回归分析,血清CTRP6和IP-16质量浓度对HDP孕妇不良妊娠结局的预测价值采用受试者操作特征曲线分析.结果 与健康组比较,HDP组血清CTRP6、IP-16质量浓度较高(P<0.05),且重度PE组血清CTRP6和IP-16质量浓度高于轻度PE组和妊娠高血压组(P<0.05).结局不良组血清CTRP6、IP-16质量浓度较结局良好组高(P<0.05),轻度及重度PE比例较结局良好组高(P<0.05).多因素分析显示,CTRP6、IP-16质量浓度和严重程度均为HDP孕妇不良妊娠结局的影响因素(OR=1.853、2.016、3.524,P<0.05).受试者操作特征曲线结果显示,血清CTRP6、IP-16质量浓度联合预测HDP不良妊娠结局的曲线下面积(0.885)显著高于CTRP6质量浓度(Z=3.347,P=0.001)和IP-16质量浓度(Z=2.537,P=0.011)单独预测的曲线下面积.结论 血清CTRP6、IP-16质量浓度与HDP孕妇病情严重程度及妊娠结局密切相关.

Objective To explore the correlation between serum levels of C1q/tumor necrosis factor related protein 6(CTRP6)and interferon γ-inducible protein-16(IP-16)in pregnant women with hypertensive disor-der of pregnancy(HDP)and pregnancy outcomes.Methods A total of 153 pregnant women with HDP admit-ted to Huai'an Maternal and Child Health Hospital Affiliated to Yangzhou University from January 2022 to June 2023 were regarded as the HDP group,and 167 healthy pregnant women as the healthy group.Accord-ing to the severity of the former group,they were further grouped into an HDP group(n=84),mild preeclamp-sia group(n=43),and severe preeclampsia group(n=26).They were also separated into a poor outcome group(n=59)and good outcome group(n=94)based on pregnancy outcomes.The influencing factors of adverse pregnancy outcomes in HDP pregnant women were analyzed using the multiple Logistic regression analysis.The predictive value of serum CTRP6 and IP-16 levels for adverse pregnancy outcomes in HDP pregnant women was analyzed using the receiver operating characteristic(ROC)curve analysis.Results Compared with the healthy group,the serum levels of CTRP6 and IP-16 in the HDP group were higher(P<0.05),and the serum levels of CTRP6 and IP-16 in the severe PE group were higher than those in the mild PE group and the pregnancy hypertension group(P<0.05).The serum levels of CTRP6 and IP-16 in the severe PE group were higher than those in the mild PE group and also higher than those in the HDP group(P<0.05).The serum levels of CTRP6 and IP-16 in the poor outcomes group were higher than those in the good outcomes group(P<0.05),and the proportions of mild and severe PE were higher than those in the good outcomes group(P<0.05).Multivariate analysis showed that CTRP6,IP-16 and severity were all influencing factors for adverse pregnancy outcomes in HDP pregnant women(OR=1.853,2.016,3.524,P<0.05).The ROC results showed that the combined prediction of serum CTRP6 and IP-16 for adverse pregnancy outcomes in HDP had an AUC(0.885)that was significantly higher than the AUC of CTRP6 alone(Z=3.347,P=0.001)and IP-16 alone(Z=2.537,P=0.011).Conclusion Serum CTRP6 and IP-16 are closely related to the severity and preg-nancy outcomes of pregnant women with HDP.

刘瑜;杨玉姣

扬州大学医学院附属淮安市妇幼保健院 产科,江苏 淮安 223001扬州大学医学院附属淮安市妇幼保健院 产科,江苏 淮安 223001

医药卫生

妊娠期高血压子痫高危妊娠妊娠结局C1q/肿瘤坏死因子相关蛋白6γ干扰素诱导蛋白-16严重程度

hypertensive disorder of pregnancyeclampsiahigh-risk pregnancypregnancy outcomeC1q/tu-mor necrosis factor related protein 6interferon γ-inducible protein-16severity

《兰州大学学报(医学版)》 2026 (7)

39-44,6

淮安市科技项目(HAB202129)

10.13885/j.issn.2097-681X.M20251171

评论